To Study the efficacy of shrungberadya Ghruta in amavata (rheumatoid arthritis) with Investigation of C-reactive protein

Single arm clinical study to assess the efficacy of shrungberadya Ghruta in amavata (rheumatoid arthritis) with special reference to C-reactive protein - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071004

Enrollment

Registered

2024-07-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D839- Common variable immunodeficiency,unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient having the signs and symptoms of Amavata as per Ayurveda view like sandhishool (pain at joints), sandhishotha (swelling over joints), sandhi stabhdhata (stiffness over joints), tivra sparshasahatva (tenderness over joints) upto 2 year. 2. The patients of Age group 20 to 60 years will be selected. 3. The patients will be selected irrespective of sex, religion.

Exclusion criteria

Exclusion criteria: 1) The patients of age below 20 yrs and above 60 yrs. 2) Pregnancy, Lactating Mother. 3) Known case of Syphilitis Arthritis, Systemic Lupus Erythematosus, Psoriatic Arthritis, Immune Compressed Diseases.

Design outcomes

Primary

Measure	Time frame
To study the effect of Shrungberadya Ghruta in Amavata with special reference to CRPTimepoint: 45 days	—

Secondary

Measure	Time frame
1) To study Amavata according to Ayurvedic literature 2)To study Rheumatoid Arthritis 3)To study C-Reactive Protein 4)To study changes in C-Reactive Protein in Amavata by using Shrungberadya GhrutaTimepoint: 12 Months	—

Countries

India

Contacts

Public ContactDr Gauri Atmaram Mulik

LRP Ayurvedic Medical College and Hospital

gaurimohite492@gmail.com8806073556

Outcome results